Global Automated Cannabis Testing Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In September 2023, Shimadzu Corporation launched the Brevis GC-2050 gas chromatograph used in various applications including cannabis testing.
• In April 2023, SC Labs, one of the leading cannabis testing company, acquired C4 Laboratories, one of the first Arizona cannabis labs, thus allowing it to be licensed and accredited in five states: California, Colorado, Michigan, Oregon, and Arizona.

This type of analyzer utilizes chromatographic techniques such as gas chromatography (GC) or liquid chromatography (LC) to separate and quantify different compounds within cannabis samples. Chromatography is particularly effective for analyzing cannabinoids, terpenes, and contaminants like pesticides and residual solvents. These analyzers provide detailed chemical profiles of cannabis products, ensuring compliance with regulatory standards and meeting consumer expectations for product safety and potency.

Spectroscopy techniques, including infrared (IR), near-infrared (NIR), and mass spectrometry (MS), are employed in spectroscopy based analyzers to analyze cannabis samples. These analyzers can quickly determine cannabinoid potency, detect contaminants, and assess product composition without the need for extensive sample preparation. Spectroscopy based analyzers are valued for their rapid analysis capabilities, making them ideal for high-throughput environments such as cannabis testing laboratories.

Cannabis and its derivatives are increasingly recognized for their potential therapeutic benefits in managing chronic pain conditions. Testing laboratories use analytical tools to quantify cannabinoids like THC (tetrahydrocannabinol) and CBD (cannabidiol) to ensure consistent potency levels in products marketed for pain relief.

Cannabidiol (CBD) has shown promise in reducing the frequency and severity of seizures in certain epilepsy syndromes. Analytical testing is crucial to confirm CBD content and ensure the absence of contaminants in cannabis-based medications used for seizure management.

Multiple sclerosis (MS) patients may use cannabis products to alleviate symptoms such as muscle spasticity and pain. Analytical testing verifies the cannabinoid profile and quality of these products to support effective symptom management and treatment outcomes.

Cannabis is also explored for its potential in treating various other conditions, including nausea, insomnia, anxiety, and neurodegenerative disorders. Analytical testing plays a pivotal role in verifying product quality, safety, and consistency across diverse therapeutic applications.

Cannabis consumers rely on testing results to make informed decisions about product selection, ensuring they receive safe and effective products that meet their therapeutic or recreational needs. Testing provides transparency regarding cannabinoid potency, terpene profiles, and the absence of harmful contaminants.

Global Automated Cannabis Testing Segment Analysis

In this report, the Global Automated Cannabis Testing Market has been segmented by Product, Service, Application, End-User and Geography.

Global Automated Cannabis Testing Market, Segmentation by Product

The Global Automated Cannabis Testing Market has been segmented by Product into Chromatography Based Analyzer and Spectroscopy Based Analyzer.
Chromatography-based analyzers are instrumental in the automated cannabis testing market, employing techniques like gas chromatography (GC) and liquid chromatography (LC) to separate and quantify various compounds present in cannabis samples. These analyzers are pivotal for determining the potency of cannabinoids such as THC and CBD, as well as identifying contaminants like pesticides, residual solvents, and heavy metals. The precision and sensitivity of chromatography ensure accurate chemical profiling of cannabis products, critical for regulatory compliance and meeting consumer expectations for safety and quality. These analyzers facilitate comprehensive analysis by providing detailed insights into the composition of cannabis samples, enabling testing laboratories to deliver reliable results efficiently.
Spectroscopy based analyzers utilize technologies such as infrared (IR), near-infrared (NIR), and mass spectrometry (MS) to analyze cannabis samples rapidly and non-destructively. These analyzers are valued for their ability to determine cannabinoid potency, detect contaminants, and assess product composition with minimal sample preparation. NIR spectroscopy, for example, allows for real-time analysis of THC and CBD levels in cannabis products, supporting high-throughput testing environments. Spectroscopy based analyzers are essential in the automated cannabis testing market for their speed, efficiency, and versatility in providing accurate analytical data that facilitates informed decision-making in product development, quality control, and regulatory compliance.

Global Automated Cannabis Testing Market, Segmentation by Service

The Global Automated Cannabis Testing Market has been segmented by Service into Potency Testing, Terpene Profiling, Heavy Metal Testing, Pesticide Screening, Microscopy Testing.

The global automated cannabis testing market is experiencing growth as the demand for accurate and reliable testing increases. This market has been segmented by service, with potency testing being one of the primary segments. Potency testing is crucial for determining the concentration of active ingredients, such as THC and CBD, in cannabis products. It ensures that products meet the required standards for safety and consistency, helping both consumers and regulators trust the quality of cannabis in the market. Automated testing systems enhance the precision and speed of these tests, reducing human error and increasing throughput.

Terpene profiling is another key service in the cannabis testing market. Terpenes are aromatic compounds found in cannabis plants, and their profile can affect the product's aroma, flavor, and therapeutic properties. By automating the terpene testing process, companies can provide more accurate and detailed profiles, allowing for a better understanding of the product's sensory characteristics and its potential therapeutic effects. Automated systems help standardize the testing process, making it more efficient and scalable, which is essential as the cannabis market continues to expand.

Heavy metal testing, pesticide screening, and microscopy testing are also important components of the automated cannabis testing market. Heavy metal testing ensures that cannabis products do not contain harmful levels of metals like lead, mercury, or arsenic, which could pose serious health risks to consumers. Pesticide screening tests for the presence of harmful chemicals that may have been used in the cultivation process. Microscopy testing, on the other hand, is used to identify contaminants such as mold or foreign particles. Automation in these testing services helps speed up the process, improve accuracy, and meet regulatory requirements, which is critical for maintaining product safety and consumer confidence in the cannabis industry.

Global Automated Cannabis Testing Market, Segmentation by Application

The Global Automated Cannabis Testing Market has been segmented by Application into Pain Management, Seizures, Sclerosis and Others.
In the realm of pain management, cannabis and its derivatives, particularly cannabinoids like THC and CBD, are increasingly recognized for their potential therapeutic benefits. Automated cannabis testing plays a crucial role in this application by ensuring accurate measurement of cannabinoid potency in products intended for pain relief. Testing laboratories utilize chromatography and spectroscopy based analyzers to quantify these compounds, providing healthcare providers and patients with reliable information to guide treatment decisions effectively.
Cannabidiol (CBD) has shown promise in reducing the frequency and severity of seizures in epilepsy patients. Automated cannabis testing is essential in this application to verify the CBD content and ensure the absence of contaminants in cannabis-based medications used for seizure management. Analytical testing technologies enable precise determination of cannabinoid profiles, supporting the development of safe and effective treatments that comply with regulatory standards.
Multiple sclerosis (MS) patients often use cannabis products to alleviate symptoms such as muscle spasticity and pain. Automated testing of cannabis samples ensures the consistency and quality of these products, confirming the presence of cannabinoids that contribute to therapeutic effects. By employing advanced analytical techniques, testing laboratories can provide accurate data on cannabinoid concentrations, empowering healthcare providers to recommend suitable cannabis treatments for managing MS symptoms.
Beyond pain management, seizures, and sclerosis, cannabis is explored for its potential in treating a wide range of conditions, including nausea, insomnia, anxiety, and neurodegenerative disorders. Automated cannabis testing supports these diverse applications by delivering comprehensive analysis of cannabinoid potency, terpene profiles, and contaminants such as pesticides and heavy metals. This analytical data aids researchers, healthcare providers, and consumers in understanding the therapeutic properties and safety of cannabis products across various medical and wellness applications.

Global Automated Cannabis Testing Market, Segmentation by End-User

The Global Automated Cannabis Testing Market has been segmented by End-User into Consumers, Regulators, Laboratories and Others.
Consumers are a significant end-user segment in the global automated cannabis testing market, relying on testing results to make informed decisions about the cannabis products they purchase and consume. Automated testing ensures transparency and accuracy in labeling, providing consumers with essential information about cannabinoid potency, terpene profiles, and the absence of contaminants like pesticides and heavy metals. By accessing reliable testing data, consumers can choose products that meet their specific needs and preferences, whether for medical purposes or recreational use.

Regulatory agencies play a crucial role in overseeing the cannabis industry and enforcing standards for product safety and quality. Automated cannabis testing supports regulators by providing comprehensive analytical data that verifies compliance with regulatory requirements. Testing laboratories utilize chromatography and spectroscopy based analyzers to assess cannabinoid content, detect contaminants, and ensure adherence to legal limits. Regulators rely on this analytical data to protect public health, enforce regulations, and maintain consumer confidence in the cannabis market.
Testing laboratories are pivotal in the automated cannabis testing market, conducting analytical testing services to assess the potency, purity, and safety of cannabis products. These laboratories utilize advanced technologies to perform accurate and reproducible analysis of cannabinoids, terpenes, and contaminants present in cannabis samples. Automated analyzers streamline testing processes, improving workflow efficiency and enabling high-throughput analysis to meet growing demand. By delivering reliable testing results, laboratories support quality control, product standardization, and regulatory compliance across the cannabis supply chain.
The "Others" category encompasses various stakeholders involved in the cannabis industry, including healthcare providers, research institutions, cultivators, and ancillary service providers. Healthcare providers rely on cannabis testing data to guide patient treatment decisions, ensuring the efficacy and safety of cannabis-based therapies. Research institutions utilize analytical insights to advance scientific knowledge and explore new applications for cannabis compounds. Cultivators benefit from testing services to optimize growing practices and ensure product consistency. Ancillary service providers may offer specialized testing solutions or support services that complement automated cannabis testing efforts, contributing to the overall development and sustainability of the cannabis market.

Global Automated Cannabis Testing Market, Segmentation by Geography

In this report, the Global Automated Cannabis Testing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The zion global services are spread across north america, europe, asia pacific, uae, dubai, saudi arabia, singapore, and others.

Global Automated Cannabis Testing Market Share (%), by Geographical Region, 2024

Europe is witnessing rapid growth in automated cannabis testing, particularly in countries where medical cannabis legalization has gained traction. Regulatory frameworks, such as the European Medicines Agency's guidelines, govern the quality and safety standards for cannabis products, necessitating advanced analytical solutions for comprehensive testing. Chromatography and spectroscopy based analyzers play a crucial role in meeting these regulatory requirements, ensuring product consistency and consumer safety. The expanding market for medicinal cannabis, coupled with increasing research initiatives, drives the adoption of automated testing technologies across Europe.

Asia-Pacific presents emerging opportunities in the automated cannabis testing market, driven by evolving regulatory landscapes and increasing acceptance of medical cannabis in countries like Australia, New Zealand, and parts of Southeast Asia. The region is witnessing a gradual shift towards legalization and regulatory frameworks that require standardized testing for cannabis products. As awareness grows and regulations evolve, there is a rising demand for advanced testing solutions to verify product quality and safety. However, cultural and regulatory challenges pose barriers to widespread adoption, requiring tailored strategies to navigate diverse market dynamics.

Middle East & Africa represent nascent but evolving markets for automated cannabis testing, with limited legalization and regulatory frameworks primarily focused on medicinal cannabis. Countries like Israel and Lesotho have established themselves as pioneers in cannabis research and cultivation, driving demand for analytical testing solutions to support growing industry needs. Challenges such as cultural perceptions, regulatory complexities, and infrastructure limitations present barriers to market growth but also underscore opportunities for future development as regulatory frameworks evolve.

This report provides an in depth analysis of various factors that impact the dynamics of Global Automated Cannabis Testing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Legalization
• Regulatory compliance
• Quality control

• Consumer safety - Consumer safety is a paramount concern in the global cannabis industry, where the quality and reliability of products directly impact public health. As cannabis legalization expands across various regions for both medical and recreational purposes, ensuring consumer safety has become increasingly critical. Automated cannabis testing plays a pivotal role in addressing this concern by providing accurate and comprehensive analysis of cannabis products.

  One of the primary aspects of consumer safety in the cannabis industry involves the determination of cannabinoid potency. Cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) have varying effects on consumers, and their accurate measurement helps ensure consistency in product labeling and dosing. Automated testing technologies, such as chromatography and spectroscopy based analyzers, enable precise quantification of cannabinoids, supporting compliance with regulatory limits and providing consumers with reliable information about product potency.

  Beyond potency, consumer safety also encompasses the detection and quantification of contaminants in cannabis products. Pesticides, heavy metals, residual solvents, and microbial pathogens can pose serious health risks if present above permissible levels. Automated testing systems facilitate the screening and identification of these contaminants, ensuring that cannabis products meet stringent safety standards before reaching consumers. Rapid and reliable detection of contaminants not only protects consumer health but also enhances trust and confidence in the regulated cannabis market.

Restraints:

• Regulatory complexity
• High initial costs
• Limited standardization

• Technological limitations - Technological limitations in automated cannabis testing present challenges that impact the industry's ability to ensure product quality, safety, and regulatory compliance effectively. These limitations span various aspects of testing methodologies and equipment used in the analysis of cannabis products.

  One of the primary technological limitations involves the sensitivity and accuracy of analytical instruments used in cannabis testing. While chromatography and spectroscopy based analyzers are widely employed for potency testing and contaminant detection, their ability to detect low levels of certain compounds, especially in complex matrices like cannabis, may be limited. This can lead to potential inaccuracies in potency measurements or the underestimation of contaminants, compromising consumer safety and regulatory compliance.

  Automated testing systems often require adequate sample preparation to ensure reliable results. However, challenges such as matrix effects, variability in sample composition, and the presence of interfering substances can affect the efficiency and reproducibility of sample preparation processes. Improvements in automated sample preparation techniques are necessary to streamline workflows and enhance the reliability of testing outcomes.

  While automated analyzers offer advantages in terms of speed and throughput compared to manual methods, limitations in throughput capacity and analytical speed can still impact testing efficiency, particularly in high-demand environments. Enhancements in instrument design and software capabilities are needed to achieve higher throughput rates and reduce turnaround times without compromising data quality.

Opportunities:

• Expansion of legal cannabis markets
• Increasing research and development

• Emerging markets - Emerging markets in the global cannabis industry present significant opportunities and challenges, driven by evolving regulatory landscapes, changing consumer attitudes, and growing recognition of the potential therapeutic benefits of cannabis products. These markets encompass regions where cannabis legalization and regulatory frameworks are still developing or undergoing reforms, creating new avenues for investment and market expansion.

  Emerging markets are characterized by shifting regulatory environments surrounding cannabis legalization for medical and/or recreational use. Countries in regions such as Latin America, Asia-Pacific, and parts of Europe are progressively introducing legislative reforms to decriminalize or regulate cannabis cultivation, distribution, and consumption. Regulatory frameworks play a crucial role in shaping market dynamics, influencing product accessibility, quality standards, and market entry strategies for businesses operating in these regions.

  Emerging markets offer substantial growth potential due to expanding consumer demand for cannabis-derived products and therapies. Rising awareness of cannabis' medicinal properties, coupled with increasing acceptance of alternative treatment options, drives market expansion in healthcare sectors addressing chronic pain, epilepsy, and other conditions. The burgeoning wellness and lifestyle segments further contribute to market growth, as consumers seek cannabis products for recreational and therapeutic purposes.

  The legalization of cannabis in emerging markets attracts domestic and international investments across cultivation, processing, distribution, and testing sectors. Opportunities abound for entrepreneurs, investors, and established cannabis companies to capitalize on first-mover advantages, establish strategic partnerships, and build robust supply chains. Investment in infrastructure development, technology transfer, and regulatory compliance services supports market growth and enhances industry sustainability.

Key players in Global Automated Cannabis Testing Market include:

• Medicinal Genomics Corp
• Hamilton Company
• PerkinElmer Inc.
• Agilent Technologies Inc.
• Todaro robotics
• QUANTUM ANALYTICS
• Shimadzu Scientific Instruments

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis